Their therapy has shown that it can and HAS caused listeriosis. THis is bad and BP will want to move to technology that is safe: ADXS therapy cannot and will NEVER cause listeriosis. ADRO is screwed. Only a matter of time for BP to move into ADXS AGGRESSIVELY!!
I am not finding this anywhere. All sept 30 2015 holdings reporting sites including Nasdaq and Broadfin 13F holding searches shows they bought another 400K and own 3.5 million now.
They have verified that the shorting is about the hold and the hold only. Read the report! What does this mean?Well, we WILL see a AVXL type move (75% in a day) once the hold is removed. Also, this should calm some fears about problems with the technology and shorts "knowing something." The technology is AWESOME and thats what matters for mid-long term investors here! A blessing for us long term holders to load up on state-of-the art, life changing therapy for a fraction of the price!!
Best thing about the latest short interest is the days to cover of 12.6 days. This is the highest number I have seen and a major indicator of fast hard short covering. With news within the next two weeks, 12.6 days to cover is going to burn shorts like we haven't seen since volkswagen. Going to be a frantic desperate search for shares. 40 maybe 60!!
holding is way too dangerous given that news on hold is imminent
Or Europe. The stock will always be only a fraction of its value as long as they stay in Israel
So, with this particular trial, how much time did they lose if they have to start all over (as you have stated -and I agree)?
But it is simply a hedge by the massive institutional interest. No more no less. Nobody has access to the FDA or even the doctors/patients. Guaranteed. When the right news comes out, the institutions will cover fast knowing that they will make money on their long plays, which will continue way after they cover into the 40s and 50s. If this technology becomes commercial, they are guaranteed a 100 price and will have covered long before. If ADXS fails, they will have a short hedge.
Author totally fails to reveal and recognize the isolated occurrence of this "problem". This was only 1 out of 230 patients. And, most importantly, this patient should have never been dosed. But clearly the dosing HELPED her anyways. Furthermore, name a drug that doesn't have problems? All drugs have caveats on who and who should not take it. Pennicillin should not be given to those with an allergy to it, for example. Come on!
So if institutions want to make a hell of a lot more money than interest, they should stop lending shares and when shorts start to panic and sell, don't lend out the shares again. Stock would be at 40 in weeks. Heck of a lot better than 6%
Shares owned by institutions are not bought on margin so how could they be borrowed by someone for shorting? And if they could be borrowed, institutions should be able to protect their shares from being shorted by a number of methods. One logical explanation is that the institutions are themselves the shorts in order to keep the price down. Borrowing shares amongst each other. Thoughts?
But Biogen earnings are going to be awesome!
Nope, anticipation of news will cause many to cover. Why cover after the news is out and lose 50%??? Always cover before the news. You must be an amateur short. Love you guys